Ahlbeck Glader C, Stegmayr B.,
Boman
J., Stenlund H., Weinehall L.,
Hallmans
G., Dahlén G.Chlamydia
Pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral
infarctions. Results from a nested case-control study in Northern
Sweden. Stroke1999; 30:
2013 - 18.
2.
Ahlm C., Juto P.,
Linderholm
M., Stegmayr B., Settergren
B.Prevalence of serum IgG antibodies to
nephropathia epidemica virus in northern Sweden. Epidemiol
Infect1994; 113: 129 -
36.
3.
Ahlm C., Juto P.,
Stegmayr
B., Settergren B., Wadell G.,
Tärnvik
A., Elgh F.Prevalence of serum
antibodies to Hantaviruses in northern Sweden as measured by recombinant nucleocapsid
proteins. Scand J Infect Dis1997;
29: 329 - 54.
4.
Ahmed E., Stegmayr B.,
Trifunovic
J., Weinehall L., Hallmans B.,
Lefvert
AKAnticardiolipin antibodies are not an
independent risk factor for stroke. An incident case-referent study within the MONICA
and Västerbotten Cohort Project.
Stroke2000; 31: 1289 -
93.
5.
Ahmed E., Trifunovic J.,
Stegmayr
B., Hallmans G., Lefvert
AKAutoantibodies against oxidatively
modified LDL do not constitute a risk factor for stroke: a nested case-control
study. Stroke1999; 30:
2541 - 46.
6.
Asplund K.Epidemiology of stroke in
Europe. The changing pattern of stroke occurrence . In: Lowenthat A,
Diener
H-C, editors. Secondary Prevention of Stroke.
Oxford Clinical Communications. Oxford:
1996; pp. 2 - 6.
7.
Asplund K.Primary and secondary
stroke prevention: Is it worth the costs? In: Wahlgren, NG,
Ahmed
N , Hårdemark H-G, editors. Update on
stroke therapy 2002 - 2003, Karolinska Stroke Update.
Stockholm; 2003, pp. 145 -
55.
Asplund K.Snuff - how
dangerous is it? The controversy continues. J Intern
Med2001; 250: 457 -
61.
10.
Asplund K.Stroke in Europe:
Widening gap between East and West. Cerebrovasc
Dis1996; 6: 3 -
6.
11.
Asplund K.The decline in
stroke mortality. An ending or a never-ending
story?Stroke2001; 32:
2218-20.
12.
Asplund K., Stegmayr B.,
Peltonen
M.From the twentieth to the twentyfirst century: a
public health perspective on stroke. In: Ginberg MD,
Bogousslavsky
J, editors. Cerebrovasculat Disease:
Pathophysiology, Diagnosis and Management. Blackwell Scientific
Publications; 1998, pp. 901 -
18.
13.
Asplund K., Nasic S.,
Janlert
U., Stegmayr B.Smokeless tobacco
as a possible risk factor for stroke in men: A nested case-control
study. Stroke2003; 34:
1754 - 59.
14.
Asplund K., Tuomilehto J.,
Kuulasmaa
K., Torppa J.Multinational stroke
mortality data at the baseline of the WHO MONICA Project . In: Meyer JS et al.
editors, Cerebral vascular disease 7, Elsevier Science
Publ.1989, pp. 167 -
70.
15.
Asplund K., Tuomilehto J.,
Stegmayr
B., Wester PO, Tunstall Pedoe
H.Diagnostic criteria and quality control of
the registration of stroke events in the MONICA project. Acta
Med Scand Suppl1988; 728: 26 -
39.
16.
Asplund K., Rajakangas A-M.,
Kuulasmaa
K., Thorvaldsen P., Bonita R.,
Stegmayr
B., Eisenblätter D., for the WHO MONICA
Project.Multinational comparison of
diagnostic procedures and management of acute stroke: The WHO MONICA
Study. Cerebrovasc Dis1996;
6: 66 - 74.
17.
Asplund K., Bonita R.,
Kuulasmaa
K., Rajakangas A-M., Feigin V.,
Schaedlich
H., Suzuki K., Thorvaldsen P.,
Tuomilehto
J., for the WHO MONICA Project. Multinational comparisons of stroke
epidemiology.Evaluation of case
ascertainment in the WHO MONICA stroke study.
Stroke1995 ; 26: 355 -
60.
18.
Bonita R., Beaglehole R.,
Asplund
K.The worldwide problem of
stroke. Curr Opinion Neurol1994;
7: 5 - 10.
19.
Cvetkovic JT , Wallberg-Jonsson
S., Stegmayr B., Rantapaa-Dahlqvist
S., Lefvert AKSusceptibility for
and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of
the TNF-alpha, IL-1beta, and IL-1Ra genes . J
Rheumatol2002; 29: 212 -
9.
20.
Dahlen GH, Weinehall L.,
Stenlund
H., Jansson JH, Hallmans G.,
Huhtasaari
F., Wall S.Lipoprotein(a) and
cholesterol levels act synergistically and apolipoprotein A-I is protective for the
incidence of primary acute myocardial infarction in middle-aged males. An incident
case-control study from Sweden. J Intern
Med1998; 244: 425 -
30.
21.
Eliasson M. , Asplund K.,
Evrin
PERegular leisure time physical activity
predicts high activity of tissue plasminogen activator: The Northern Sweden MONICA
Study. Int J Epidemiol1996;
25(6): 1182 -
8.
22.
Eliasson M. , Evrin PE,
Lundblad
D.Fibrinogen and fibrinolytic variables in
relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA
Study . J Clin Epidemiol1994 ;
47(5): 513 -
24.
23.
Eliasson M. , Fatah-Ardalani F.,
Blombäck
M.Fibrin gel structure in smokers and
non-smokers in the northern Sweden MONICA Study. A pilot study .
Fibrinolysis1999; 13: 163
- 67.
24.
Eliasson M. , Asplund K.,
Evrin
P-E., Lundblad D.Relationship of
cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and
serum insulin. The Northern Sweden MONICA Study.
Atherosclerosis1995; 113: 41 -
53.
25.
Eliasson M. , Jansson JH,
Nilsson
P., Asplund K.Increased levels
of tissue plasminogen activator antigen in essential hypertension. A population-based
study in Sweden. J Hypertens1997;
15(4): 349 -
56.
26.
Eliasson M. , Lindahl B.,
Lundberg
V., Stegmayr B.No increase in
the prevalence of diabetes between 1986 and 1999 in subjects 25 - 64 years of age in
northern Sweden . Diabet Med2002 ;
19: 874 - 80.
27.
Eliasson M., Asplund K.,
Evrin
P-E., Huhtasaari F., Johansson
I.Plasma fibrinogen, fibrinolysis and
(pro)vitamins: is there a
connection?Fibrinolysis1995;
9: 87 - 92.
28.
Eliasson M., Asplund K.,
Evrin
PE, Lindahl B., Lundblad
D.Hyperinsulinemia predicts low tissue
plasminogen activator activity in a healthy population: the Northern Sweden MONICA
Study. Metabolism1994;
43(12): 1579 -
86.
29.
Eliasson M., Evrin PE,
Lundblad
D., Asplund K., Rånby
M.Influence of gender, age and sampling time
on plasma fibrinolytic variables and fibrinogen.
Fibrinolysis1993 ; 7: 316
- 23.
30.
Eliasson M., Roder ME,
Dinesen
B., Evrin PE, Lindahl
B.Proinsulin, intact insulin, and
fibrinolytic variables and fibrinogen in healthy subjects. A population
study. Diabetes Care1997;
20(8):
1252-5.
31.
Emmelin M., Weinehall L.,
Stegmayr
B., Dahlgren L., Stenlund H.,
Wall
S.Self-rated ill-health strengthens the
impact of bio-medical risk factor load in predicting stroke, especially for men. An
incident case-referent study . J
Hypertens2003; 21: 887 -
96.
32.
Forsberg L. , de Faire U.,
Marklund
S., Andersson P., Stegmayr B.,
Morgenstren
R.Phenotype determination of common Pro-Leu
polymorphism in human glutathione perocidase 1. Blood Cells Mol
Dis2000; 26: 423 -
26.
33.
Gaziano JM, Gaziano TA,
Glynn
RJ, Sesso HD, Ajani UA,
Stampfer
MJ, et al. Light-to-moderate alcohol
consumption and mortality in the Physicians' Health Study enrollment
cohort. J Am Coll Cardiol2000;
35: 96 - 105.
34.
Glader E-L. , Stegmayr B.,
Johansson
L., Hulter-Åsberg K., Wester
PODifferences in long-term outcome between
patients treated in stroke units and general wards. A 2-year follow-up of stroke
patients in Sweden. Stroke2001;
32: 2124-30.
35.
Haftenberger M., Lahmann PH,
Panico
S., Gonzalez CA, Seidell JC,
Boeing
H., Giurdanella MC, Krogh V.,
Bueno-de-Mesquita
HB, Peeters PH, Skeie G.,
Hjartaker
A., Rodriguez M., Quiros JR,
Berglund
G., Janlert U., Khaw KT,
Spencer
EA, Overvad K., Tjonneland A.,
Clavel-Chapelon
F., Tehard B., Miller AB,
Klipstein-Grobusch
K., Benetou V., Kiriazi G.,
Riboli
E., Slimani N.Overweight,
obesity and fat distribution in 50 to 64-year-old participants in the European
Prospective Investigation into Cancer and Nutrition (EPIC) .
Public Health Nutr2002;
5(6B): 1147 -
62.
36.
Hallgren CG , Hallmans G.,
Jansson
J-H., Marklund S., Schütz A.,
Strömberg
U., Vessby B., Skerfving
S.Intake of fish and risk of myocardial
infarction - roles of methylmercury and polyunsaturated fatty acids.
Br J Nutr2001; 86: 397 -
404.
37.
Hedberg GE, Jacobsson KA,
Janlert
U., Langendoen S.Risk indicators
of ischemic heart disease among male professional drivers in Sweden.
Scand J Work Environ Health. 1993 ;
19(5): 326 -
33.
38.
Holmgren G. , Costa PMP,
Andersson
C., Asplund K., Steen L.,
Beckman
L., Nylander P-O., Teixeira A.,
Saraiva
MJM, Costa PPGeographical
distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier
frequency and prevalence rate . J Med
Genet1994; 31: 101 -
4.
39.
Huhtasaari F., Asplund K.,
Wester
POCardiovascular risk factors in the
Northern Sweden MONICA Study. Acta Med
Scand1988; 224: 99 -
108.
40.
Huhtasaari F., Asplund K.,
Lundberg
V., Stegmayr B., Wester
POTrends in cardiovascular risk factors in
the northern Sweden MONICA study: Who are the winners?Cardiovasc
Risk Factors1993; 3: 215 -
21.
41.
Huhtasaari F., Asplund K.,
Lundberg
V., Stegmayr B., Wester
POTobacco and myocardial infarction - is
snuff less dangerous than cigarettes?Br Med
J1992 ; 305: 1252 -
56.
42.
Huhtasaari F., Lundberg V.,
Eliasson
M., Janlert U., Asplund
K.Smokeless tobacco as a possible risk
factor for myocardial infarction: a population-based study in middle-aged men [see
comments]. J Am Coll Cardiol1999;
34(6): 1784 -
90.
43.
Hägg S. , Söderberg S.,
Ahrén
B., Olsson T., Mjörndal
T.Leptin concentrations are increased in
subjects treated with clozapine or conventional antipsychotics.
J Clin Psychiatry2001; 62:
843 - 48.
44.
Ingall T., Asplund K.,
Mahonen
M., Bonita R.A multinational
comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke
study. Stroke2000 ; 31:
1054-61.
45.
Janlert U., Asplund K.,
Weinehall
L.Unemployment and cardiovascular risk
indicators. Data from the MONICA survey in northern Sweden.
Scand J Soc Med1991; 20:
14 - 18.
46.
Janlert U., Asplund K.,
Weinehall
L., Orth-Gomér K., Undén
A-L.Men who never married. A socio-medical
study in northern Sweden. Arctic Med
Res1992; 51: 72 -
80.
47.
Johansson G. , Wikman Å.,
Åhren
A-M., Hallmans G., Johansson
I.Underreporting of energy intake in
repeated 24-hour recalls related to gender, age, weight status, day of interview,
educational level, reported food intake, smoking habits and area of
living. Public Health Nutr2001;
4: 919 - 27.
48.
Johansson I. , Hallmans G.,
Asplund
K.Are risk factors for atherosclerosis in an
area with high incidence of cardiovascular disease related to
diet?Scand J Nutr1992;
36: 154 - 60.
49.
Johansson I. , Wikman Å.,
Hallmans
G.Changes in food selection in northern
Sweden - the MONICA surveys 1986 and 1990. Scand J
Nutr1994; 38: 56 -
61.
50.
Johansson J. , Hallmans G.,
Wikman
Å., Biessy C., Riboli E.,
Kaaks
R.Validation and calibration of food
frequency questionnaire measurements in the Northern Sweden Health and Disease
cohort . Public Health Nutr2002;
5: 487 - 96.
51.
Johansson L. , Jansson JH,
Boman
K., Nilsson T., Stegmayr B.,
Hallmans
G.Tissue plasminogen activator inhibitor-1
(PAI-1) and tPA-PAI-1 complex as risk factors for the development of first-ever
stroke . Stroke2000; 32:
26 - 32.
52.
Johansson L. , Jansson JH,
Boman
K., Nilsson T., Stegmayr B.,
Hallmans
G.Prospective study on soluble
thrombomodulin and von Willbrand factor and the risk of ischemic and hemorrhagic
stroke. Thromb Haemost2002 ;
87: 211 - 7.
53.
Jonsson N., Asplund
K.Does pretreatment with statins improve
clinical outcome after stroke? A pilot case-referent study.
Stroke2001; 32: 1112 -
15.
54.
Kaaks R., Lukanova A.,
Rinaldi
S., Biessy C., Söderberg S.,
Olsson
T., Stenman UH, Riboli E.,
Hallmans
G., Stattin P.Interrelationships
between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases
and controls. Eur J Cancer Prev2003;
12: 309 - 15.
55.
Kaaks R., Lundin E.,
Rinaldi
S., Manjer J., Biessy C.,
Söderberg
S., Lenner P., Janzon L.,
Riboli
E., Berglund G., Hallmans
G.Prospective study of IGF-I, IGFbinding
proteins, and breast cancer risk, in northern and southern Sweden.
Cancer Causes Control2002; 13:
307 - 16.
56.
Kristensen B. , Malm J.,
Carlberg
B., Fagerlund M., Stegmayr B.,
Olsson
T.Epidemiology and etiology of ischemic
stroke in young adults aged 18 to 44 years in northern Sweden.
Stroke1997; 28: 1702 -
9.
57.
Ladenvall P. , Johansson L.,
Jansson
JH, Jern S., Nilsson TK,
Tjarnlund
A., et al. Tissue-type plasminogen activator
- 7,351C/T enhancer polymorphism is associated with a first myocardial
infarction . Thromb Haemost2002;
87(1): 105 -
9.
58.
Lindahl B. Lifestyle and health .The
role of insulin resistance syndrome in cardiovascular disease and diabetes. The effects
of lifestyle intervention (dissertation) . Umeå:
Umeå University ; 1998.
59.
Lindahl B., Asplund K.,
Hallmans
G.High serum insulin, insulin resistance and
their associations with cardiovascular risk factors. The Northern Sweden MONICA
population study. J Intern Med1993;
234: 263 - 70.
60.
Lindahl B., Asplund K.,
Eliasson
M., Evrin PEInsulin resistance
syndrome and fibrinolytic activity: the northern Sweden MONICA study.
Int J Epidemiol1996;
25(2): 291 -
9.
61.
Lindahl B., Weinehall L.,
Asplund
K., Hallmans G.Screening for
impaired glucose tolerance. Results from a population-based study in 21,057
individuals. Diabetes Care1999;
22: 1988-92.
62.
Lindahl B., Johansson I.,
Huhtasaari
F., Hallmans G., Asplund
K.Coffee drinking and blood cholesterol-
effects of brewing method, food intake and life style. J Intern
Med1991 ; 230: 299 -
305.
63.
Lindahl B., Dinesen B.,
Eliasson
M., Roder M., Hallmans G.,
Stegmayr
B.High proinsulin levels precede first-ever
stroke in a nondiabetic population .
Stroke2000; 31(12):
2936-41.
64.
Lindahl B., Dinesen B.,
Eliasson
M., Roder M., Jansson JH,
Huhtasaari
F., Hallmans G.High proinsulin
concentration precedes acute myocardial infarction in a nondiabetic
population. Metabolism1999 ;
48(9): 1197 -
202.
65.
Lindeberg S. , Eliasson M.,
Lindahl
B., Ahren B.Low serum insulin in
traditional Pacific Islanders - the Kitava Study.
Metabolism1999; 48(10):
1216 - 9.
66.
Lindeberg S. , Söderberg S.,
Ahrén
B., Olsson T.Large differences
in serum leptin levels between nonwesternized and westernized populations: the Kitava
study. J Intern Med2001;
249: 553 - 58.
67.
Lindeberg S. , Berntorp E.,
Carlsson
R., Eliasson M., Marckmann
P.Haemostatic variables in Pacific Islanders
apparently free from stroke and ischaemic heart disease - the Kitava
Study . Thromb Haemost1997;
77(1): 94 -
8.
68.
Lindgärde F. , Söderberg S.,
Olsson
T., Ercilla MB, Correa LR,
Ahrén
B.Overweight is associated with lower serum
leptin in Peruvian Indian than in Caucasian women: A dissociation contributing to low
blood pressure?Metabolism2001;
50: 325 - 9.
69.
Lindholm L. , Rosén M.,
Weinehall
L., Asplund K.Cost effectiveness
and equity of a community based cardiovascular disease prevention programme in Norsjo,
Sweden. J Epidemiol Community Health.
1996; 50: 190 -
5.
70.
Lukanova A. , Söderberg S.,
Stattin
P., Palmqvist R., Lundin E.,
Biessy
C., Rinaldi S., Riboli E.,
Hallmans
G., Kaaks R.Nonlinear
relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio
with indices of adiposity and plasma insulin concentrations (Sweden).
Cancer Causes Control2002; 13:
509 - 16.
71.
Lundberg V.Women versus men with
myocardial infarction: sex differences in risk factors, management and outcome
(dissertation). Umeå: Umeå
University; 2000.
72.
Lundberg V. , Asplund K.,
Evrin
PE, Eliasson M.Oral
contraceptives and oestrogen replacement therapy as determinants of plasma fibrinogen
level and fibrinolytic activity. The Northern Sweden MONICA Study.
Fibrinolysis1998; 12: 328
- 34.
73.
Lundberg V. , Wikström B.,
Boström
S., Asplund K.Exploring sex
differences in case fatality in acute myocardial infarction or coronary death events in
the Northern Sweden MONICA project. J Intern
Med.2002; 251: 1 -
10.
74.
Lundberg V. , Stegmayr B.,
Asplund
K., Eliasson M., Huhtasaari
F.Diabetes as a risk factor for myocardial
infarction: population and gender perspectives . J Intern
Med1997; 241: 485 -
92.
75.
Lundberg V., Tolonen H.,
Stegmayr
B., Kuulasmaa K., Asplund
K.Oral contraceptives and hormonal replacement
therapy in the WHO MONICA-Project . Maturitas, in press.
76.
Malm J., Kristensen B.,
Stegmayr
B., Fagerlund M., Koskonin
L-O.Three-year survival and functional
outcome of patients with idiopathic adult hydrocephalus.
Neurology2000; 55: 576 -
78.
77.
Marklund SL , Nilsson P.,
Israelsson
K., Schampi I., Peltonen M.,
Asplund
K.Two variants of extracellularsuperoxide
dismutase: relationship to cardiovascular risk factors in an unselected middle-aged
population . J Intern Med1997;
242: 5 - 14.
78.
Messner T., Huhtasaari
F.Cardiovascular drugs and the risk of death
in acute myocardial infarction in northern Sweden MONICA patients.
Int J Circumpolar Health2001; 60:
366 - 74.
79.
Messner T., Lundberg
V.Trends in sudden cardiac death in the
northern Sweden MONICA area 1985 - 99 . J Intern
Med2003; 253: 320 -
8.
80.
Messner T., Lundberg V.,
Stegmayr
B.Cardiovascular risk factor levels differ
between rural and urban areas of the Northern Sweden MONICA Project.
Scand J Public Health , in press.
81.
Messner T., Lundberg V.,
Wikstrom
B.A temperature rise is associated with an
increase in the number of acute myocardial infarctions in the subarctic
area. Int J Circumpolar Health2002;
61: 201 - 7.
Messner T., Häggström I.,
Sandahl
I., et al. No covariation between the
geomagnetic activity and the incidence of acute myocardial infarction in the circumpolar
area of northern Sweden . Int J
Biometeorol2002; 46: 90 -
4.
84.
Mogren I., Högberg U.,
Stegmayr
B., Lindahl B., Stenlund
H.Fetal exposure, heredity and risk
indicators for cardiovascular disease in a Swedish welfare cohort.
Int J Epidemiol2001; 30:
853 - 62.
85.
Mooe T., Eriksson P.,
Stegmayr
B.Ischemic stroke after acute myocardial
infarction a population based study .
Stroke1997; 28: 762 -
7.
86.
Mooe T., Olofsson B-O.,
Eriksson
P., Stegmayr B.Ischemic stroke:
impact of a recent myocardial infarction.
Stroke1999; 30: 997 -
1001.
87.
Nilsson M., Trehn G.,
Asplund
K.Use of complementary and alternative
medicine remedies in Sweden. A population-based longitudinal study within the northern
Sweden MONICA Project . J Intern Med2001;
250: 1 - 9.
88.
Nylander P-O. , Asplund K.,
Beckman
L., Stegmayr B., Johansson
I.Population studies in northern Sweden.
XVIII. Geographical covariation between hypercholesterolemia and Finnish genetic
influence. Hum Hered1993 ;
43: 147 - 54.
89.
Peltonen M. , Asplund
K.Age-period cohort effects on stroke
mortality in Sweden 1969 - 1993 and forecasts up to the year 2003.
Stroke1996; 27: 1981 -
5.
90.
Peltonen M. , Asplund
K.Age-period-cohort effects on ischaemic
heart disease mortality in Sweden from 1969 to 1993, and forecasts up to
2003 . Eur Heart J1997;
18: 1307 - 12.
91.
Peltonen M. , Asplund K.,
Rosén
M.Social patterning of myocardial infarction
and stroke in Sweden: incidence and survival. Am J
Epidemiol2000; 151: 283 -
92.
92.
Peltonen M. , Stegmayr B.,
Asplund
K.Time trends in long-term survival after
stroke. The Northern Sweden MONICA Study 1985 - 1994.
Stroke1998; 29: 1358 -
65.
93.
Peltonen M. , Lundberg V.,
Huhtasaari
F., Asplund K.Marked improvement
survival after acute myocardial infarction in men but not in women. The Northern Sweden
MONICA Study 1985 - 1994. J Intern
Med2000; 247: 579 -
87.
94.
Peltonen M. , Huhtasaari F.,
Stegmayr
B., Lundberg V., Asplund
K.Secular trends in social patterning of
cardiovascular risk factor levels in Sweden. The Northern Sweden MONICA Study 1986 -
1994 . J Intern Med1998;
244: 1 - 9.
95.
Persson M., Carlberg B.,
Mjörndal
T., Asplund K., Bohlin J.,
Lindholm
L.1999 WHO/ISH guidelines applied to a 1999
MONICA sample from northern Sweden . J
Hypertens2002; 20: 29 -
35.
96.
Persson M., Carlberg B.,
Weinehall
L., Nilsson L., Stegmayr B.,
Lindholm
LHRisk stratification by guidelines compared
with risk assessment by risk equations applied to a MONICA sample.
J Hypertens2003 ; 21(6):
1089 - 95.
97.
Rask E.Neuroendocrine studies in
obesity and insulin resistance (dissertation) .
Umeå: Umeå University;
2002.
98.
Rask E., Olsson T.,
Söderberg
S., Andrew R., Livingstone DE,
Johnson
O., Walker BRTissuespecific
dysregulation of cortisol metabolism in human obesity . J Clin
Endocrinol Metab2001; 86: 1418 -
21.
99.
Rask E., Olsson T.,
Söderberg
S., Johnson O., Seckl J.,
Holst
J., Ahrén B.Impaired incretin
response after a mixed meal is associated with insulin resistance in nondiabetic
men. Diabetes Care2001;
24: 1640-5.
100.
Rask E., Walker BR,
Soderberg
S., Livingstone DE, Eliasson M.,
Johnson
O., et al. Tissue-specific changes in
peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid
dehydrogenase type 1 activity. J Clin Endocrinol
Metab2002; 87(7):
3330-6.
101.
Rodu B., Stegmayr B.,
Nasic
S., Asplund K.Impact of
smokeless tobacco on smoking: A Swedish paradox explained . J
Intern Med2002; 252: 398 -
404.
102.
Rodu B., Stegmayr B.,
Nasic
S., Cole P., Asplund
K.The influence of smoking and smokeless
tobacco use on weight among men. Accepted for publication in J
Intern Med.
103.
Rodu B., Stegmayr B.,
Nasic
S., Cole P., Asplund
K.Evolving patterns of tobacco use in
northern Sweden. J Intern Med2003;
253(6): 660 -
5.
104.
Rosengren A., Stegmayr B.,
Johansson
I., Huhtasaari F., Wilhelmsen
L.Coronary Risk factors, diet and vitamins
as possible explanatory factors of the Swedish North-South gradient in cardiovascular
disease. J Intern Med1999;
246: 577 - 86.
105.
Sarti C., Stegmayr B.,
Tolonen
H., Mähönen M., Tuomilehto J.,
Asplund K for the WHO MONICA Project. Are changes in mortality from
stroke caused by changes in stroke event rates or case fatality? Results from the WHO
MONICA Project. Stroke2003;
34: 1833-41.
106.
Sikström C. , Beckman L.,
Hallmans
G., Asplund K.Transferrin types,
iron-binding capacity and body iron stores. Hum
Hered1993; 43: 337 -
41.
107.
Slunga L., Asplund K.,
Johnson
O., Dahlén GHLp(a) lipoprotein
in a randomly selected 25 - 64-year-old population - the Northern Sweden MONICA
Study. J Clin Epidemiol1993;
46: 617 - 24.
108.
Stattin P. , Söderberg S.,
Hallmans
G., Bylund A., Kaaks R.,
Stenman
UH, Bergh A., Olsson
T.Leptin is associated with increased
prostate cancer risk: a nested case-referent study. J Clin
Endocrinol Metab2001; 86:
1341-5.
109.
Stegmayr B.Stroke in the Community.
Studies on Risk Factors, Incidence, Case Fatality, Severity and Secular Trends in the
Northern Sweden MONICA Project, with Multinational Comparisons.
Umeå1996.
110.
Stegmayr B. , Asplund
K.Diabetes as a risk factor for stroke. A
population perspective. Diabetologia1995 ;
38: 1061 - 68.
111.
Stegmayr B. , Asplund
K.Exploring the declining case fatality in
acute stroke. Population-based observations in the Northern Sweden MONICA
Project . J Intern Med1996;
240: 143 - 9.
112.
Stegmayr B. , Asplund
K.Informed consent for genetic research on
blood stored for more than a decade: a population-based study.
Br Med J2002; 325: 634 -
5.
113.
Stegmayr B. , Asplund
K.Measuring stroke in the population:
quality of routine statistics in comparison with a population-based stroke
registry . Neuroepidemiology1992;
11(4 - 6): 204 -
13.
114.
Stegmayr B. , Asplund K.,
Wester
POTrends in incidence, case fatality rate,
and severity of stroke in northern Sweden, 1985 - 1991 .
Stroke1994; 25: 1738 -
45.
115.
Stegmayr B. , Asplund K.,
Hulter-Asberg
K., Norrving B., Peltonen M.,
Terent
A., et al. Stroke units in their natural
habitat: can results of randomized trials be reproduced in routine clinical practice?
Riks-Stroke Collaboration. Stroke1999;
30: 709 - 14.
116.
Stegmayr B. , Asplund K.,
Kuulasmaa
K., Rajakangas A-M., Thorvaldsen P.,
Tuomilehto
J.Stroke incidence and mortality correlated
to stroke risk factors in the WHO MONICA Project. An ecological study of 18
populations. Stroke1997;
28: 1367 - 74.
117.
Stegmayr B., Johansson I.,
Huhtasaari
F., Moser U., Asplund
K.Use of smokeless tobacco and cigarettes
and plasma levels of antioxidant vitamins . Int J Vitam Nutr
Res1993; 63: 195 -
200.
118.
Stegmayr B., Vinogradova T.,
Malyutina
S., Peltonen M., Nikitin Y.,
Asplund
K.Widening gap of stroke between east and
west Eight-year trends in occurrence and risk factors in Russia and
Sweden. Stroke2000; 32:
2 - 8.
119.
Stegmayr B., Harmsen P.,
Rajakangas
A-M., Rastenyté D., Sarti C.,
Thorvaldsen
P., Tuomilehto J.Stroke around
the Baltic Sea - incidence, case fatality and population risk factors in Denmark,
Finland, Sweden and Lithuania. Cerebrovasc
Dis1996; 6: 80 -
8.
Söderberg S., Ahren B.,
Eliasson
M., Dinesen B., Olsson
T.The association between leptin and
proinsulin is lost with central obesity. J Intern
Med2002; 252(2):
140 - 8.
122.
Söderberg S., Olsson T.,
Eliasson
M., Johnson O., Ahren
B.Plasma leptin levels are associated with
abnormal fibrinolysis in men and postmenopausal women . J Intern
Med1999; 245(5):
533 - 43.
123.
Söderberg S., Ahren B.,
Eliasson
M., Dinesen B., Brismar K.,
Olsson
T.Circulating IGF binding protein-1 is
inversely associated with leptin in non-obese men and obese postmenopausal
women. Eur J Endocrinol2001;
144(3): 283 -
90.
Söderberg S., Ahrén B.,
Jansson
JH, Johnson O., Hallmans G.,
Asplund
K., Olsson T.Leptin is
associated with increased risk of myocardial infarction. J
Intern Med1999; 246: 409 -
18.
126.
Söderberg S., Ahrén B.,
Stegmayr
B., Johnson O., Wiklund PG,
Weinehall
L., Hallmans G., Olsson
T.Leptin is a risk marker for first-ever
hemorrhagic stroke in a population-based cohort.
Stroke1999; 30: 328 -
37.
127.
Söderberg S., Olsson T.,
Eliasson
M., Johnson O., Brismar K.,
Carlstrom
K., et al. A strong association between
biologically active testosterone and leptin in non-obese men and women is lost with
increasing (central) adiposity. Int J Obes Relat Metab
Disord2001; 25(1):
98 - 105.
128.
Thorvaldsen P., Asplund K.,
Kuulasmaa
K., Rajakangas A-M., Schroll M
for the WHO MONICA Project. Stroke incidence, case fatality, and mortality in the WHO
MONICA Project. Stroke1995;
26: 361 - 7.
129.
Thögersen AM, Jansson JH,
Boman
K., Nilsson TK, Weinehall L.,
Huhtasaari
F., Hallmans G.High plasminogen
activator inhibitor and tissue plasminogen activator levels in plasma precede a first
acute myocardial infarction in both men and women: evidence for the fibrinolytic system
as an independent primary risk factor.
Circulation1998; 98: 2241
- 7.
130.
Thögersen AM, Nilsson TK,
Dahlen
G., Jansson J-H., Boman K.,
Huhtasaari
F., Hallmans G.Homozygosity for
the plasma homocyst(e)ine are not associated with greater than normal risk of a first
myocardial infarction in Northern Sweden. Coron Artery
Dis2001; 12: 85 -
90.
131.
Tolonen H. , Mähönen M.,
Asplund
K., Rastenyte D., Kuulasmaa K.,
Vanuzzo
D., Tuomilehto J. for the WHO MONICA
Project.Do trends in population levels of
blood pressure and other cardiovascular risk factors explain trends in stroke event
rates? Comparisons of 15 populations in 9 countries within the WHO MONICA Stroke
Project. Stroke2002; 33:
2367-75.
132.
Truelsen T. , Mähönen M.,
Tolonen
H., Asplund K., Bonita R.,
Vanuzzo
D. for the WHO MONICA
Project.Trends in stroke and coronary heart
disease in the WHO MONICA Project.
Stroke2003; 34:
1346-52.
133.
Wake DJ, Rask E.,
Livingstone
DE, Söderberg S., Olsson T.,
Walker
BRLocal and systemic impact of
transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose
tissue in human obesity. J Clin Endocrinol
Metab2003; 88:
3983-8.
134.
Walker BR, Söderberg S.,
Lindahl
B., Olsson T.Independent effects
of obesity and cortisol in predicting cardiovascular risk factors in men and
women. J Intern Med2000 ;
247: 198 - 204.
135.
Weinehall L.Partnership for health
(dissertation). Umeå: Umeå
University, 1997.
136.
Weinehall L, Lewis C, eds.
Population-wide interventions to reduce the risk of cardiovascular
disease in rural communities: experiences from Sweden and the US. Scand J
PublHealth2001; Suppl
56.
137.
Weinehall L., Hallgren C-G.,
Westman
G., Janlert U., Wall
S.Reduction of selection bias in primary
prevention of cardiovascular disease through involvement of primary health
care. Scand J Prim Health Care1998;
16: 171 - 76.
138.
Weinehall L., Hellsten G.,
Boman
K., Hallmans G., Asplund K.,
Wall
S.Can a sustainable community intervention
reduce the health gap? 10 year of evaluation of a Swedish community intervention program
for the prevention of cardiovascular disease . Scand J Public
Health2001; Suppl 56: 59 -
68.
139.
Weinehall L., Lewis C.,
Nafziger
AN, Jenkins PL, Erb TA,
Pearson
TA, Wall S.Different outcomes
for different intervention focus: A cross-country comparison of community intervention
in rural Sweden and US populations. Scand J Public
Health2001; 29 (suppl 56):
46 - 58.
140.
Weinehall L., Ohgren B.,
Persson
M., Stegmayr B., Boman K.,
Hallmans
G., Lindholm LHHigh remaining
risk in poorly treated hypertension: The `rule of halves' still exists.
J Hypertens2002; 20: 2081
- 8.
141.
Weinehall L., Johnson O.,
Jansson
JH, Boman K., Huhtasaari F.,
Hallmans
G., Dahlén GH, Wall
S.Perceived Health modifies the effect of
biomedical risk factors in the prediction of acute myocardial infarction. An incident
case-control study from Northern Sweden . J Intern
Med1998; 243: 99 -
107.
142.
Weinehall L., Westman G.,
Hellsten
G., Boman K., Hallmans G.,
Pearson
TA, Wall S.Shifting the
distribution of risk: Results of a community intervention in a Swedish programme for the
prevention of cardiovascular disease. J Epidemiol Community
Health1999 ; 53: 243 -
50.
143.
WHO MONICA Project (prepared by
Asplund
K, Feigin V, Schaedlich H,
Kuulasmaa
K , Rajakangas AM, Suzuki K):
Stroke Event Registration Quality Report.
WHO1992.
144.
WHO MONICA Project
(prepared by Asplund K, Rajakangas A-M, Kuulasmaa K, Thorvaldsen P, Bonita R, Stegmayr B,
Suziki K, Eisenblätter
D.): Multinational comparison of
diagnostic procedures and management of acute stroke. The WHO MONICA
Study. Cerebrovasc Dis1996;
6: 66 - 74.
145.
WHO MONICA Project (prepared by
Kuulasmaa
K, Asplund K, Pekkanen J,
Rajakangas
AM, Zhang M): Stroke Event Registration
Data Book 1982 - 1987.
WHO1992.
146.
WHO MONICA Project (prepared by
Suzuki
K, Asplund K, Kuulasmaa K,
Rajakangas
AM , Ruokokoski E): Quality stroke
subtype data in the MONICA stroke event registration.
WHO1992.
147.
Who MonicaStroke
Investigators (prepared by K Asplund): Stroke in MONICA. Ann
Epidemiol1993; 3:
534.
148.
Wolf-Maier K. , Cooper RS,
Banegas
JR, Giampaoli S., Hense HW,
Joffres
M., Kastarinen M., Poulter N.,
Primatesta
P., Rodriguez-Artalejo F., Stegmayr B.,
Thamm
M., Tuomilehto J., Vanuzzo D.,
Vescio
F.Hypertension prevalence and blood pressure
levels in 6 European countries, Canada, and the United
StatesJAMA2003; 289:
2363 - 9.
149.
Öhgren B., Weinehall L.,
Stegmayr
B.What else adds to hypertension in
predicting stroke? An incident case-referent study. J Intern
Med2000; 248: 475 -
82.
150.
Östman PO, Anneroth G.,
Johansson
I., Stegmayr B., Skoglund
A.Life-style survey of patients with oral
lichenoid reactions. Acta Odontol
Scand1996; 54: 96 -
101.
151.
DECODE-study group on behalf of the European Diabetes Epidemiology Study
Group.Will new diagnostic criteria for
diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European
epidemiological data. BMJ1998 ;
317: 371 - 5.
152.
DECODE-study group on behalf of the European Diabetes Epidemiology Study
Group.Consequences of the new diagnostic
criteria for diabetes in older men and women. Diabetes
Care1999; 22: 1667 -
71.
153.
DECODE-study group on behalf of the European Diabetes Epidemiology Study
Group.Glucose tolerance and mortality.
Comparison of the WHO and the ADA diagnostic criteria.
Lancet1999; 354: 617 -
21.
154.
DECODE-study group on behalf of the European Diabetes Epidemiology Study
Group.Is fasting glucose sufficient to
define diabetes? Epidemiological data from 20 European centres.
Diabetologia1999; 42: 647
- 54.
155.
DECODE Study Group.The new
diagnostic criteria and their impact on the global prevalence of
diabetes . Medicographia Issue1999;
62214, 2003: 354 -
9.
156.
DECODE Study Group.Glucose
tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic
criteria. Clin Lab2000;
46(5 - 6):
311.
157.
DECODE-study group on behalf of the European Diabetes Epidemiology Study
Group. (2001) Glucose
tolerance and cardiovascular mortality. Comparison of the 2-hour and the ADA fasting
diagnostic criteria. Arch Intern Med2001;
161: 397 - 404.
158.
DECODE Study Group.Is the
current definition for diabetes relevant to mortality risk from all causes and
cardiovascular and non-cardiovascular diseases?Diabetes
Care2003; 26: 688 -
96.
159.
DECODE study group.Gender
difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly
diagnosed diabetes. Diabetologia2003;
46: 608 - 17.
160.
DECODE study group.Age and
sex specific prevalence of diabetes and impaired glucose regulation in 13 European
cohorts. Diabetes Care2003 ;
26: 61 - 9.
161.
DECODE study
group.Prevalence of the metabolic syndrome
and its relation to all-cause and cardiovascular mortality in non-diabetic European men
and women. Arch Intern Med (accepted).
162.
DECODE study group.Hyperinsulinemia
as a risk factor for cardiovascular mortality in nondiabetic European men and
women. (manuscript).
163.
Dobson A., Miettinen H.,
Rajakangas
A-M., Kuulasmaa K., for the WHO MONICA
project.Mild myocardial infarction - a
classification problem in epidemiologic studies . J Clin
Epidemiol1997; 50: 3 -
13.
164.
Dobson A., Filipiak B.,
Kuulasmaa
K., Beaglehol R., Stewart A.,
Hobbs
M., Parsons R., Keil U.,
Greiser
E., Korhonen H., Tuomilehto
J.Relations of changes in coronary disease
rates and changes in risk factor levels; Methodological issues and a practical
example. Am J Epidemiol1996;
143: 1025-34.
165.
Doering A. , Pajak A.,
Ferrario
M., Grafnetter D., Kuulasmaa K. for
the WHO MONICA
Project.Methods of total cholesterol
measurement in the baseline survey of the who MONICA Project.
Rev Épidémiol Santé Publicque1990; 38:
445 - 61.
166.
Evans A., Dobson A.,
Ferrario
M., Kuulasmaa K., Moltchanov V.,
Sans
S., Tunstall-Pedoe H., Tuomilehto J.,
Wedel
H., Yarnell J., for the WHO MONICA
Project.The who monica project: Changes in
coronary risk in the 1980s.
Atherosclerosis1998; XI:
49 - 55.
167.
Hense HW, Kuulasmaa K.,
Zaborskis
A., Kupsc W., Tuomilehto J. for
the WHO MONICA
Project.Quality assessment of blood
pressure measurements in epidemiologic surveys. The impact of last digit preference and
proportions of identical duplicate measurements. Rev Epidémiol
Santé Publicque1990; 38: 463 -
68.
168.
Keil U., Kuulasmaa K. for
the WHO MONICA
Project.Risk factors and medical
care. Int J Epidemiol1989;
18: 46 - 55.
169.
Kuulasmaa K., Dobson A. for
the WHO MONICA
Project.Statistical issues related to
following populations rather than individuals over time.
Bulletin of the International Statistical Institute: Proceedings of the 51st
Session; 1997 Aug 18 - 26; Istanbul, Turkey.
Voorburg: International Statistical Institute;
1997. Book 1:295 - 8.
170.
Molarius A. , Seidell JC,
Kuulasmaa
K., Dobson AJ, Sans S. for
the WHO MONICA
Project.Smoking and relative body weight:
an international perspective from the WHO MONICA Project. J
Epidemiol Community Health1997; 51:
252 - 60.
171.
Molarius A. , Parsons RW,
Dobson
AJ, Evans A., Fortmann SP,
Jamrozik
K., Kuulasmaa K., Moltchanov V.,
Sans
S., Tuomilehto J., Puska
P.Trends in cigarette smoking in 36
populations from the early 1980s to the mid-1990s: Findings from the WHO Monica
Project . Am J Public Health.2001;
91: 206 - 12.
172.
Pajak A., Kuulasmaa K.,
Tuomilehto
J., Ruokokoski E. for the WHO MONICA
Project.Geographical variation in the major
risk factors of coronary heart disease in men and women aged 35 - 64
years. World Hlth Stat Quart1988;
41: 115 - 40.
173.
Stewart AW, Kuulasmaa K.,
Beaglehole
R. for the WHO MONICA
Project.Ecological analysis of the
association between mortality and major risk factors of cardiovascular
disease. Int J Epidemiol1994;
23: 505 - 16.
174.
Thorvaldsen P. , Kuulasmaa K.,
Rajakangas
AM, Rastenyte D., Sarti C.,
Wilhelmsen
L., for the WHO MONICA
Project.Stroke trends in the WHO MONICA
Project . Stroke. 1997;
28: 500 - 6.
175.
Tunstall-Pedoe H. For the WHO MONICA
Project.The World Health Organization MONICA
Project (monitoring of trends and determinants in cardiovascular diseases): A major
international collaboration. J Clin
Epidemiol1988; 41: 105 -
14.
176.
Tunstall-Pedoe H.For the WHO
MONICA Project. World's largest and longest heart study produces some surprises.
European Congress
ofCardiology1998.
177.
Tunstall-Pedoe H., Kuulasmaa K.,
Amouyel
P., Arveiler D., Rajakangas A-M.,
Pajak
A. For the WHO MONICA
Project.Myocardial infarction and coronary
deaths in the World Health Organization Monica Project: Registration procedures, event
rates and case fatality rates in 38 populations from 21 countries in 4
continents. Circulation1994;
90: 583 - 612.
178.
Tunstall-Pedoe H., Kuulasmaa K.,
Mähönen
M., Tolonen H., Ruokokoski E.,
Amouyel
P. For the WHO MONICA
Project.Contribution of trends in survival
and coronary-event rates to changes in coronary heart disease mortality: 10-year results
from 37 Who Monica Project populations.
Lancet1999; 353: 1547 -
57.
179.
Tunstall-Pedoe H., Vanuzzo D.,
Hobbs
M., Mahonen M., Cepaitis Z.,
Kuulasmaa
K., Keil U.Estimation of
contribution of changes in coronary care to improving survival, event rates, and
coronary heart disease mortality across the Who Monica Project populations [see
comments] . Lancet2000;
355: 688 - 700.
180.
Wolf HK, Tuomilehto J.,
Kuulasmaa
K., Domarkiene S., Cepaitis Z.,
Molarius
A., Sans S., Dobson A.,
Keil
U., Rywik S.Blood pressure
levels in the 41 populations of the WHO MONICA Project . J Human
Hypertension1997; 11: 733 -
42.